Department of Health and Social Care (DHSC) has issued a medicine supply notification for Norditropin (somatropin) Flexpro® 10mg/1.5ml and Norditropin (somatropin) NordiFlex® 5mg/1.5ml, 10mg/1.5ml and 15mg/1.5ml solution for injection pre-filled pens.
Tier 2 – medium impact
Date of issue 3rd January 2023
Norditropin (somatropin) Flexpro® 10mg pen is out of stock until early February 2023. Once supplies return, stock of all strengths, will be limited for the remainder of 2023 and will need to be reserved only for patients already established on this therapy.
Norditropin (somatropin) NordiFlex® 5mg, 10mg and 15mg pens will be out of stock from midFebruary 2023 for the remainder of 2023 and cannot support an uplift in demand for the above shortage.
Omnitrope (somatropin) SurePal® 5mg/1.5ml, 10mg/1.5ml and 15mg/1.5ml solution for injection cartridges remain available and will be able to support a full increase in demand during this time.
Sciensus and Alcura have the capacity to offer virtual device training for all switched patients.
All Omnitrope (somatropin) SurePal® patients will receive 4 weekly deliveries until all patients have been switched.
A copy of this medicine supply notification, including further information for pharmacy teams, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
The post Medicine Supply Notification: Norditropin (somatropin) Flexpro® 10mg/1.5ml and Norditropin (somatropin) NordiFlex® 5mg/1.5ml, 10mg/1.5ml and 15mg/1.5ml solution for injection pre-filled pens appeared first on PSNC Website.